Richter Consulting Supports Restructuring of $400MM Manufacturer of Private Label Pharmaceuticals
Richter Consulting was retained by second lien lenders to assess short-term liquidity, EBITDA forecast, and operational challenges.
We addressed post-acquisition integration issues, product recalls, lost customers/SKUs, new product development, and customer growth.
We also supported a restructuring of the credit facility with a sensitized EBITDA and cash flow forecast by business unit
(incorporating detailed analysis of add-backs, cost savings, and synergies) with key financial and operational recommendations.